Affiliation:
1. Department of Biochemistry, Center for Biomedical Research, University of Texas Health Science Center, Tyler, Texas 75708
2. Department of Medical Microbiology and Immunology, College of Medicine, University of Toledo, Toledo, Ohio 43614
Abstract
ABSTRACT
Activation of complement represents one means of natural resistance to infection from a wide variety of potential pathogens. Recently, properdin, a positive regulator of the alternative pathway of complement, has been shown to bind to surfaces and promote complement activation. Here we studied whether properdin-mediated complement activation occurs on the surface of
Chlamydia pneumoniae
, an obligate intracellular Gram-negative bacterium that causes 10 to 20% of community-acquired pneumonia. We have determined for the first time that the physiological P
2
, P
3
, and P
4
forms of human properdin bind to the surface of
Chlamydia pneumoniae
directly. The binding of these physiological forms accelerates complement activation on the
Chlamydia pneumoniae
surface, as measured by C3b and C9 deposition. Finally, properdin-depleted serum could not control
Chlamydia pneumoniae
infection of HEp-2 cells compared with normal human serum. However, after addition of native properdin, the properdin-depleted serum recovered the ability to control the infection. Altogether, our data suggest that properdin is a pattern recognition molecule that plays a role in resistance to
Chlamydia
infection.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference57 articles.
1. Agarwal, S., et al. 2010. An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. J. Immunol. 185:507-516.
2. Belland, R., D. M. Ojcius, and G. I. Byrne. 2004. Chlamydia. Nat. Rev. Microbiol. 2:530-531.
3. Belland, R. J., S. P. Ouellette, J. Gieffers, and G. I. Byrne. 2004. Chlamydia pneumoniae and atherosclerosis. Cell. Microbiol. 6:117-127.
4. Bertsche, A., M. H. Wagner, R. Bollmann, M. Obladen, and U. Felderhoff-Mueser. 2008. An unusual manifestation of a neonatal Chlamydia infection. J. Child Neurol. 23:948-949.
5. Biesecker, G., and H. J. Muller-Eberhard. 1980. The ninth component of human complement: purification and physicochemical characterization. J. Immunol. 124:1291-1296.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献